Jensen Pb

891 total citations
35 papers, 663 citations indexed

About

Jensen Pb is a scholar working on Molecular Biology, Oncology and Nephrology. According to data from OpenAlex, Jensen Pb has authored 35 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Nephrology. Recurrent topics in Jensen Pb's work include Cancer therapeutics and mechanisms (9 papers), Lung Cancer Research Studies (7 papers) and Parathyroid Disorders and Treatments (6 papers). Jensen Pb is often cited by papers focused on Cancer therapeutics and mechanisms (9 papers), Lung Cancer Research Studies (7 papers) and Parathyroid Disorders and Treatments (6 papers). Jensen Pb collaborates with scholars based in Denmark, Finland and Sweden. Jensen Pb's co-authors include Maxwell Sehested, Björn Wíkström, Eero Honkanen, Pieter L. Rensma, Jean-Marie Krzesinski, Francis Verbeke, Seppo W. Langer, Raymond Vanholder, Wim Van Biesen and Erland J.F. Demant and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jensen Pb

32 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jensen Pb Denmark 11 291 161 144 120 110 35 663
G Raabe Germany 9 335 1.2× 40 0.2× 155 1.1× 142 1.2× 78 0.7× 24 780
S. Meijer Netherlands 19 180 0.6× 212 1.3× 183 1.3× 80 0.7× 208 1.9× 53 959
Sait Şen Türkiye 18 375 1.3× 95 0.6× 179 1.2× 38 0.3× 256 2.3× 92 968
Francesco Tartaglia Italy 19 161 0.6× 120 0.7× 107 0.7× 105 0.9× 98 0.9× 57 976
Laura Cosmai Italy 21 234 0.8× 276 1.7× 514 3.6× 46 0.4× 325 3.0× 56 997
Ivo Lukitsch United States 7 164 0.6× 45 0.3× 67 0.5× 40 0.3× 93 0.8× 12 644
Motokazu Matsuura Japan 13 190 0.7× 144 0.9× 81 0.6× 26 0.2× 195 1.8× 30 538
Luciano Colangelo Italy 18 354 1.2× 256 1.6× 96 0.7× 75 0.6× 225 2.0× 64 1.1k
Emily Robinson United States 9 106 0.4× 159 1.0× 166 1.2× 234 1.9× 181 1.6× 15 588
Ryutaro Shimazaki Japan 12 199 0.7× 160 1.0× 55 0.4× 18 0.1× 63 0.6× 20 466

Countries citing papers authored by Jensen Pb

Since Specialization
Citations

This map shows the geographic impact of Jensen Pb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jensen Pb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jensen Pb more than expected).

Fields of papers citing papers by Jensen Pb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jensen Pb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jensen Pb. The network helps show where Jensen Pb may publish in the future.

Co-authorship network of co-authors of Jensen Pb

This figure shows the co-authorship network connecting the top 25 collaborators of Jensen Pb. A scholar is included among the top collaborators of Jensen Pb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jensen Pb. Jensen Pb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palarasah, Yaseelan, Rikke Borg, Else‐Marie Bladbjerg, et al.. (2024). The contact system in chronic kidney disease and hemodialysis – A cross-sectional study. Thrombosis Research. 245. 109229–109229.
2.
Petersen, Jeanette Krogh, Jensen Pb, Mia Dahl Sørensen, & Bjarne Winther Kristensen. (2016). Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors. PLoS ONE. 11(12). e0169129–e0169129. 16 indexed citations
3.
Verbeke, Frederick, Wim Van Biesen, Eero Honkanen, et al.. (2011). 1.1 PROGNOSTIC VALUE OF COMBINED ASSESSMENT OF AORTIC STIFFNESS AND CALCIFICATION IN DIALYSIS PATIENTS: OUTCOME DATA OF THE CALCIFICATION OUTCOME IN RENAL DISEASE (CORD) STUDY. Artery Research. 5(4). 138–138. 1 indexed citations
4.
Verbeke, Francis, Wim Van Biesen, Eero Honkanen, et al.. (2010). Prognostic Value of Aortic Stiffness and Calcification for Cardiovascular Events and Mortality in Dialysis Patients. Clinical Journal of the American Society of Nephrology. 6(1). 153–159. 179 indexed citations
5.
Verbeke, Francis, Raymond Vanholder, Pieter L. Rensma, et al.. (2010). Role of aortic calcification, stiffness and wave reflections in cardiovascular risk in dialysis patients: Baseline data from the CORD study. Artery Research. 4(3). 81–81. 7 indexed citations
6.
7.
Honkanen, Eero, Leena I. Kauppila, Björn Wíkström, et al.. (2008). Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrology Dialysis Transplantation. 23(12). 4009–4015. 116 indexed citations
8.
Lassen, Ulrik, Morten Mau‐Sørensen, Jensen Pb, et al.. (2004). A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results. Journal of Clinical Oncology. 22(14_suppl). 7207–7207. 3 indexed citations
9.
Pb, Jensen, et al.. (2000). Changes in cardiac muscle mass and function in hemodialysis patients during growth hormone treatment.. PubMed. 53(1). 25–32. 13 indexed citations
10.
Hansen, Torben Bæk, et al.. (2000). Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.. PubMed. 53(2). 99–107. 47 indexed citations
11.
Langer, Seppo W., Maxwell Sehested, & Jensen Pb. (2000). Treatment of anthracycline extravasation with dexrazoxane.. PubMed. 6(9). 3680–6. 79 indexed citations
12.
Pb, Jensen, Torben Bæk Hansen, Jan Frystyk, et al.. (1999). Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.. PubMed. 52(2). 103–9. 19 indexed citations
13.
Jensen, Charlotte Harken, et al.. (1998). Quantification of the N-terminal propeptide of human procollagen type I (PINP): Comparison of ELISA and RIA with respect to different molecular forms. Clinica Chimica Acta. 269(1). 31–41. 21 indexed citations
14.
Pb, Jensen, et al.. (1997). Heparin-Free Hypothermal Hemodialysis at 20°C Improves Biocompatibility. Blood Purification. 15(3). 200–207. 7 indexed citations
15.
Pb, Jensen, et al.. (1996). Flow cytometry analysis of pan-T-, CD4(+)-, CD8(+)-, and pan-B lymphocytes in blood samples obtained from healthy, nontreated rats: comparison of lymphocyte subpopulations in blood samples obtained from rat heart and tail.. PubMed. 46(5). 579–81. 1 indexed citations
16.
Pb, Jensen, et al.. (1996). What are the clinical benefits of correcting the catabolic state in haemodialysis patients?. PubMed. 85. 47–51. 3 indexed citations
17.
Pb, Jensen, et al.. (1996). Development of Anti-OKT3 Antibodies After OKT3 Treatment. Scandinavian Journal of Urology and Nephrology. 30(3). 227–230. 5 indexed citations
18.
Friche, Ellen, Jensen Pb, Maxwell Sehested, Erland J.F. Demant, & N. Nissen. (1990). The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.. PubMed. 2(9). 297–303. 72 indexed citations
19.
Pb, Jensen, et al.. (1977). Dihydrotachysterol (DHT) and supplemental calcium therapy in dialysis patients.. PubMed. 6. 184–90. 1 indexed citations
20.
Rask-Madsen, J, Jensen Pb, & J. O. Lund. (1973). Rectal hyperpolarization following intestinal bypass for obesity. Gut. 14(5). 390–392. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Raabe Breakdown of academic impact, for papers by S. Meijer Breakdown of academic impact, for papers by Sait Şen Breakdown of academic impact, for papers by Francesco Tartaglia Breakdown of academic impact, for papers by Laura Cosmai Breakdown of academic impact, for papers by Ivo Lukitsch Breakdown of academic impact, for papers by Motokazu Matsuura Breakdown of academic impact, for papers by Luciano Colangelo Breakdown of academic impact, for papers by Emily Robinson Breakdown of academic impact, for papers by Ryutaro Shimazaki
Rankless by CCL
2026